Abstract:Acetamiprid is a pesticide active substance with insecticidal action whose approval was renewed by Commission Implementing Regulation (EU) 2018/113. In January 2022, the EFSA PPR Panel published a statement following a request from the European Commission to advise on human health or the environment based on new scientific evidence presented by France during the decision‐making phase. In July 2022, by means of a further mandate received from the European Commission, EFSA was requested to provide advice if new information and any other scientific evidence that has become available since the assessment conducted for the renewal in 2018 warrant re‐evaluation of (i) toxicological parameters used for the risk assessment of acetamiprid during the renewal process, including toxicological endpoints; (ii) the residue definition for acetamiprid in products of plant origin; and (iii) the safety of existing maximum residue levels (MRLs). Meanwhile, the applicant of acetamiprid in the EU submitted new toxicology studies regarding the toxicological profile of the metabolite IM‐2‐1. Furthermore, the European Commission was made aware that several recent publications in scientific literature were made available after the literature searches conducted by EFSA. As the new data could affect the advice that EFSA was expected to deliver through the 2022 mandate, EFSA was further requested to consider this information by means of a revised mandate received in September 2023. As regards re‐evaluation of point (i) in this statement, this was addressed by an EFSA Working Group integrating all the available evidence. The results of the weight of evidence indicated that there are major uncertainties in the body of evidence for the developmental neurotoxicity (DNT) properties of acetamiprid and further data are therefore needed to come to a more robust mechanistic understanding to enable appropriate hazard and risk assessment. In view of these uncertainties, the EFSA WG proposed to lower the acceptable daily intake (ADI) and acute reference dose (ARfD) from 0.025 to 0.005 mg/kg body weight (per day). A revised residue definition for risk assessment was proposed for leafy and fruit crops as sum of acetamiprid and N‐desmethyl‐acetamiprid (IM‐2‐1), expressed as acetamiprid. Regarding pulses/oilseeds, root crops and cereals, the new data received did not indicate a need to modify the existing residue definition for risk assessment, which therefore remains as parent acetamiprid. Regarding the residue definition for enforcement, the available data did not indicate a need to modify the existing definition because acetamiprid is still a sufficient marker of the residues in all crop groups. Considering the new health‐based guidance values derived in the present statement, a risk for consumer has been identified for 38 MRLs currently in place in the EU Regulation. Consequently, EFSA recommended to lower the existing MRLs for 38 commodities based on the assessment of fall‐back Good Agricultural Practices received within an ad hoc data call. Some fall‐back MRLs proposals require further risk management considerations.

Modification of the existing maximum residue levels for flonicamid in various crops

Modification of the existing maximum residue level for flonicamid in honey

Modification of the existing maximum residue levels for cycloxydim in various crops

Modification of the existing maximum residue levels for dichlorprop-P in cereal grains

Modification of the existing maximum residue level for methoxyfenozide in aubergines

Evaluation of confirmatory data following the Article 12 MRL review for fluroxypyr

Focussed review of the existing maximum residue levels for lambda‐cyhalothrin in light of the unspecific residue definition and the existing good agricultural practices for the substance gamma‐cyhalothrin

Review of the existing maximum residue levels for Beta‐cyfluthrin and Cyfluthrin according to Article 12 of Regulation (EC) No 396/2005

Modification of the existing maximum residue levels for chlorpyrifos‐methyl in kaki/Japanese persimmon and granate apple/pomegranate

Review of the existing maximum residue levels for difenoconazole according to Article 12 of Regulation (EC) No 396/2005

Residue Behaviors and Risk Assessment of Flonicamid and Its Metabolites in the Cabbage Field Ecosystem.

Evaluation of confirmatory data following the Article 12 MRL review for quizalofop-P-ethyl, quizalofop-P-tefuryl and propaquizafop and modification of the existing maximum residue levels for quizalofop-P-tefuryl

Review of the existing maximum residue levels for ipconazole according to Article 12 of Regulation (EC) No 396/2005

Statement on the toxicological properties and maximum residue levels of acetamiprid and its metabolites

Evaluation of confirmatory data following the Article 12 MRL review for myclobutanil

Evaluation of confirmatory data following the Article 12 MRL review and modification of the existing maximum residue levels for aluminium phosphide and magnesium phosphide

Peer review of the pesticide risk assessment of the active substance flufenacet

Evaluation of confirmatory data following the Article 12 MRL review for fenbuconazole

Updated reasoned opinion on the toxicological properties and maximum residue levels (MRLs) for the benzimidazole substances carbendazim and thiophanate-methyl

Maximum levels of cross‐contamination for 24 antimicrobial active substances in non‐target feed. Part 6: Macrolides: tilmicosin, tylosin and tylvalosin

Occurrence and ecological risks of flonicamid and its metabolites in multiple substrates from intensive rice–vegetable rotations in tropical China